Lilly CEO Details $850M Plans

Eli Lilly and Co. is making an $850 million investment on manufacturing and research in the U.S. in 2017 and that includes Indianapolis. CEO Dave Ricks talks about what’s fueling the investment, and if more could be on the way.... Read More

Lilly Diabetes to Sponsor NASCAR

What do Eli Lilly and Co. and NASCAR have in common? A lot, these days. The Indianapolis-based pharmaceutical company is expanding its partnership, signing a multi-year deal to become the “Official Diabetes Health Partner of NASCAR.”... Read More

Research Pegs Indiana’s Life Sciences Impact at $63B

The state’s life sciences initiative says the industry’s impact continues to get bigger. BioCrossroads says research from the Indiana Business Research Center at the Indiana University Kelley School of Business shows the industry’s economic impact in 2015 rose to $63 billion. In all, more than 56,000 employees are tied to nearly 1,700 Indiana life sciences […]... Read More

Roche CEO: IBRI Will Succeed Where Others Have Failed

The chief executive officer of Roche Diagnostic North America says Governor Eric Holcomb’s endorsement of the Indiana Biosciences Research Institute is key to the collaboration that he believes will ultimately make the facility a global leader. Jack Phillips tells Inside INdiana Business the institute is about halfway to its $350 million funding goal. ... Read More

Purdue’s $250M Life Sciences Investment

Purdue is pumping $250 million into life sciences research. Executive Vice President For Research and Partnerships Suresh Garimella weighs-in on the impact the investment will have on both the university and the state.... Read More

Outgoing Lilly CEO Talks Triumphs, Disappointments

Eli Lilly and Co. CEO John Lechleiter sits down for his last interview before leaving the drug maker’s top office. He talks about triumphs, the Alzheimer’s disappointment and what’s next for him and wife Sarah as they head into retirement.... Read More

Elanco Establishing Itself as Industry Leader

Greenfield-based Elanco U.S. Inc. has announced an agreement to add the companion animal vaccine portfolio of one of its competitors. The $885 million deal with Boehringer Ingelheim Vetmedica Inc. involves dozens of cat, dog and rabies vaccines, as well as an Iowa manufacturing facility. Shawn McKee, Elanco’s Senior Director of Companion Animal U.S. explains what the […]... Read More

IBRI Hires European Bioscience Giant

The Indiana Biosciences Research Institute has hired the man who will set the agenda for the research and innovation that comes out of the center. Rainer Fischer, who has been named chief scientific and innovation officer, most recently led the Fraunhofer Institute for Molecular Biology and Applied Ecology in Germany.... Read More

Inside Wild Pitch Yeast

He’s a cancer researcher by day and a beer expert by night. Meet the IU scientist who’s launched Wild Pitch Yeast and is providing yeast to craft breweries making special Bicentennial-ales. ... Read More

2016 ‘Indiana Companies to Watch’

Fourteen businesses state-wide were recognized as the 2016 ‘Indiana Companies to Watch’. Newly appointed Indiana Economic Development Corporation Vice President and Chief Innovation Officer Ian Steff talks about the importance of the event to Governor Mike Pence’s $1 billion innovation and entrepreneurship initiative.... Read More